Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pharmacodynamic, pharmacokinetic and safety study of FSN-013 in healthy Japanese women
jRCT2080223983Phase 2Completed
- Sponsor
- Fuji Pharma Co., Ltd.
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of estetrol in contraception (2 arms), sponsored by Fuji Pharma Co., Ltd. Primary endpoint: Primary pharmacodynamic, pharmacokinetic, and safety endpoints. Started Jul 2018; status: completed.
02
Drugs
estetrol
03
Conditions
contraception
Beyond the preview
Go deeper on jRCT2080223983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223983.